Pudendal neuralgia (PN) is a debilitating condition characterized by chronic neuropathic pain in the distribution of the pudendal nerve, affecting the perineum, genitals, and rectum. It presents a significant clinical challenge due to its complex pathophysiology, varied clinical presentation, and limited understanding among healthcare providers. This review aims to provide a comprehensive overview of pudendal neuralgia, encompassing its etiology, pathophysiology, clinical manifestations, diagnostic approaches, and management strategies.

Etiology and Pathophysiology: Pudendal neuralgia can arise from various etiologies, including entrapment/compression of the pudendal nerve, traumatic injury, pelvic surgery, childbirth-related trauma, inflammatory conditions, and idiopathic causes. The pudendal nerve, derived from the sacral spinal roots (S2-S4), innervates the perineal region, including the genitals, perineum, and anus. Entrapment of the pudendal nerve can occur at multiple sites along its course, including Alcock’s canal (ischial spine), piriformis muscle, and obturator internus muscle. Chronic compression or irritation of the nerve leads to neurogenic inflammation, demyelination, and sensitization, contributing to the development of neuropathic pain.

Clinical Presentation: The clinical presentation of pudendal neuralgia is characterized by chronic, burning, stabbing, or shooting pain localized to the perineum, genitalia, and rectum. Patients may report exacerbation of pain with sitting, sexual activity, defecation, or prolonged standing. Additionally, sensory disturbances, such as numbness, tingling, or hypersensitivity, may be present in the affected areas. Pelvic floor dysfunction, including pelvic floor muscle spasm and sexual dysfunction, is commonly associated with pudendal neuralgia, further complicating the clinical picture.

Diagnostic Evaluation: The diagnosis of pudendal neuralgia requires a comprehensive evaluation, including thorough history-taking, physical examination, and adjunctive diagnostic studies. Clinical assessment may reveal tenderness over the pudendal nerve distribution, altered sensation, and pelvic floor muscle dysfunction. Imaging studies such as magnetic resonance imaging (MRI) and ultrasound may help identify structural abnormalities or nerve entrapment sites. Electrophysiological studies, including pudendal nerve terminal motor latency (PNTML) and pudendal nerve somatosensory evoked potentials (PSEP), can aid in confirming the diagnosis and localizing the site of nerve dysfunction.

Management Strategies: The management of pudendal neuralgia is multimodal and individualized, aiming to alleviate pain, improve functional status, and enhance quality of life. Conservative treatment modalities include pharmacotherapy (e.g., tricyclic antidepressants, anticonvulsants, neuropathic pain medications), pelvic floor physical therapy, nerve blocks (e.g., pudendal nerve block, ganglion impar block), and behavioral interventions (e.g., cognitive-behavioral therapy, relaxation techniques). For refractory cases, surgical interventions such as pudendal nerve decompression or neuromodulation may be considered, although outcomes can be variable and should be weighed against potential risks and benefits.

Conclusion: Pudendal neuralgia is a debilitating condition characterized by chronic neuropathic pain in the distribution of the pudendal nerve, posing significant challenges in diagnosis and management. A multidisciplinary approach, incorporating conservative and interventional strategies tailored to individual patient needs, is essential for optimizing outcomes and improving quality of life for individuals with pudendal neuralgia. Continued research efforts aimed at elucidating the underlying mechanisms and identifying novel therapeutic targets hold promise for advancing the care of patients with this complex and often overlooked condition.